×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GPCR – structure therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GPCR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
08:30 am
gpcr
Structure Therapeutics to Participate in the Jefferies London Healthcare Conference
High
Report
Structure Therapeutics to Participate in the Jefferies London Healthcare Conference
11/13
04:05 pm
gpcr
Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights
Medium
Report
Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights
11/13
04:02 pm
gpcr
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity [Yahoo! Finance]
Medium
Report
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity [Yahoo! Finance]
11/13
04:01 pm
gpcr
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity
Medium
Report
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity
10/31
08:30 am
gpcr
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024
Medium
Report
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024
10/22
02:09 pm
gpcr
Structure Therapeutics: Potential To Have Best-In-Class GLP-1 Agonist For Obesity Patients [Seeking Alpha]
Low
Report
Structure Therapeutics: Potential To Have Best-In-Class GLP-1 Agonist For Obesity Patients [Seeking Alpha]
9/23
08:53 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Medium
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
9/23
07:59 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $118.00 price target on the stock.
Medium
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $118.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
05:46 pm
gpcr
Form SC 13G/A Structure Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SC 13G/A Structure Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
10:26 am
gpcr
Form SC 13G Structure Therapeutics Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SC 13G Structure Therapeutics Filed by: JANUS HENDERSON GROUP PLC
11/14
09:33 am
gpcr
Form SC 13G/A Structure Therapeutics Filed by: Avoro Capital Advisors LLC
Medium
Report
Form SC 13G/A Structure Therapeutics Filed by: Avoro Capital Advisors LLC
11/13
04:17 pm
gpcr
Form 10-Q Structure Therapeutics For: Sep 30
Low
Report
Form 10-Q Structure Therapeutics For: Sep 30
11/13
04:11 pm
gpcr
Form 8-K Structure Therapeutics For: Nov 13
Low
Report
Form 8-K Structure Therapeutics For: Nov 13
11/12
12:52 pm
gpcr
Form SC 13G Structure Therapeutics Filed by: Capital Research Global Investors
Low
Report
Form SC 13G Structure Therapeutics Filed by: Capital Research Global Investors
11/12
10:35 am
gpcr
Form SC 13G/A Structure Therapeutics Filed by: FMR LLC
Low
Report
Form SC 13G/A Structure Therapeutics Filed by: FMR LLC
11/8
10:53 am
gpcr
Form SC 13G/A Structure Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
Low
Report
Form SC 13G/A Structure Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: